June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Comparison of Baseline Visual Function for Patients in Low Vision Intervention Trial (LOVIT) and LOVIT 2
Author Affiliations & Notes
  • Joan Stelmack
    VA Affairs-Bldg 113, Hines VA Hospital, Hines, IL
    Ophthalmology and Visual Science, Illinois Eye and Ear Infirmary, Chicago, IL
  • Xiaoyin Tang
    VA Affairs-Bldg 113, Hines VA Hospital, Hines, IL
  • Yongliang Wei
    VA Affairs-Bldg 113, Hines VA Hospital, Hines, IL
  • Scott Sayers
    VA Affairs-Bldg 113, Hines VA Hospital, Hines, IL
  • Robert W Massof
    Wilmer Eye Institute, Johns Hopkins, Baltimore, MD
  • Footnotes
    Commercial Relationships Joan Stelmack, None; Xiaoyin Tang, None; Yongliang Wei, None; Scott Sayers, None; Robert Massof, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 512. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joan Stelmack, Xiaoyin Tang, Yongliang Wei, Scott Sayers, Robert W Massof, ; Comparison of Baseline Visual Function for Patients in Low Vision Intervention Trial (LOVIT) and LOVIT 2. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):512.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine if the patients enrolled in LOVIT 2 have greater visual ability at baseline than the patients enrolled in LOVIT. The LOVIT RCTs were conducted to evaluate the outcomes of different models of outpatient LVR provided by the Department of Veterans Affairs. Both RCTs included patients with macular diseases; habitual visual acuity (better-seeing-eye) <20/100 and >20/500 (LOVIT), best-corrected visual acuity (better-seeing-eye) VA <20/50 and >20/200 (LOVIT 2).

Methods: Rasch analysis with Andrich rating scale model was performed on VA Low Vision Visual Functioning Questionnaire-48 responses at baseline for LOVIT and LOVIT 2 participants combined to look for evidence of study-related DIF, and to compare measures for different functional domains of visual ability (overall, reading, mobility, visual motor and visual information processing).

Results: Mean habitual visual acuity (better-seeing-eye) of LOVIT patients was 1.1 logMar SD (0.2). Mean best-corrected visual acuity (better-seeing-eye) of LOVIT 2 patients was 0.6 logMAR (SD 0.2). LOVIT 2 participants have significantly more visual ability in all areas except mobility (p<.001 for overall, reading, visual motor and visual information processing). There is agreement between LOVIT and LOVIT 2 item measures (no uniform DIF). However, there is some significant study-dependent non-uniform DIF with LOVIT 2 estimates nosier than LOVIT estimates.

Conclusions: Patients in LOVIT 2 have greater visual ability at baseline than patients in LOVIT.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×